AT A GLANCE
- 2026 trend
- Subtle · strategic · natural-looking
- Belotero
- A product family—not one universal gel
- Le Moir reference
- ₩300K · Belotero 1 cc · before VAT
- Safety first
- Vascular symptoms need urgent care
Why the ‘not filled’ look is a 2026 conversation
The American Academy of Facial Plastic and Reconstructive Surgery reported a clear shift away from visibly overdone results in its February 2026 release on the 2025 member survey. Patients were described as seeking earlier, subtler and more strategic changes, while neurotoxins and fillers remained among the most common minimally invasive procedures.
That trend is useful only when it is translated into a medical plan. ‘Natural’ is not a standardized dose, a universal face shape or a promise that filler will be invisible. It usually means agreeing on a limited concern, preserving expression and accepting that the best recommendation may be less product, a staged review or no filler.
A responsible consultation separates a line, hollow or structural support issue from skin laxity, swelling, muscle movement and bone shape. Adding gel to the wrong diagnosis can make a face look heavier without solving the original concern.
- Bring neutral, unfiltered photographs rather than a single edited reference image.
- Describe what bothers you before naming a product or amount.
- Agree on a stopping point and review plan before treatment begins.
Belotero is a family—so ask to see the exact syringe
Belotero is a hyaluronic-acid filler family, not one interchangeable formula. Belotero Balance (+), Belotero Volume (+) Lidocaine and Belotero Intense (+) Lidocaine have different product characteristics and US approvals. In 2026, the FDA approved Belotero Volume (+) for selected mid-face volume deficits and Belotero Intense (+) for lip augmentation; Belotero Balance (+) already had named US indications for moderate-to-severe facial wrinkles and folds and infraorbital hollowing.
An approval in one country does not automatically describe Korean labeling, and one Belotero product should not be substituted for another in a price comparison. Before injection, ask for the full product name, sealed box, lot information, expiration date, volume and whether lidocaine is included.
Le Moir's public menu currently says ‘Belotero, 1 cc, full face’ but does not name the exact variant. This guide therefore treats the clinic price as a family-level reference and does not claim that it matches Belotero Balance, Volume or Intense sold elsewhere.
A subtle result comes from restraint, placement and anatomy
Hyaluronic-acid gel can attract water and create smoothing or support, but product rheology is only one part of the outcome. The planned tissue plane, amount per area, facial movement, skin thickness, previous filler and injector technique all matter.
One cubic centimeter is a package quantity—not a recommendation to place all of it in one area. It also does not predict the visible change. A small amount in a thin, mobile area can be noticeable, while a broader structural concern may not be appropriately addressed by filler at all.
The conceptual image below shows a small gel form supporting a surface line. It is not an injection map, depth guide or representation of how Belotero should be placed in a specific face.

‘Natural’ should not erase product-specific boundaries
A product can look soft or flexible in marketing material and still be a prescription medical implant with area-specific labeling. The FDA notes that approvals are based on controlled studies in specified facial or hand areas and that it may not have reviewed every filler for every location.
The current US Belotero Balance (+) information names nasolabial folds and infraorbital hollowing. Newer Belotero Volume (+) and Intense (+) approvals cover different areas and tissue planes. Those distinctions are one reason a traveler should not book ‘one syringe anywhere’ from a menu alone.
Korean availability and authorized uses can differ from the US and Europe. The treating physician should explain why the exact product suits the proposed area, how much is planned and what alternative—including no injection—was considered.
The safety conversation matters more than the aesthetic trend
Common filler reactions include swelling, bruising, redness, pain, tenderness, itching and temporary firmness. Infection, nodules, delayed inflammation, discoloration and asymmetry can also occur. Illness, vaccination or dental work has been associated with delayed inflammation near prior filler in post-market reports.
The most serious risk is unintended injection into a blood vessel. The FDA warns that vascular occlusion can reduce tissue blood supply and lead to necrosis, vision abnormalities including blindness or stroke. Unusual pain, blanching or white-gray-blue skin, vision change or stroke-like symptoms during or shortly after treatment require immediate medical attention.
Ask who will inject, what anatomy and complication training they have, whether an emergency protocol is current and where urgent ophthalmic or hospital care would occur. Hyaluronidase may be part of managing some hyaluronic-acid filler problems, but it is not a guarantee against harm and carries its own risks.
- Disclose every previous filler, thread, implant, surgery and energy treatment—even if years ago.
- Discuss severe allergies, lidocaine sensitivity, bleeding risk, immune conditions, active skin problems, cold sores, pregnancy or breastfeeding.
- Do not proceed while the planned product or emergency pathway is unclear.
Planning Belotero during a Seoul visit
A short Seoul stay can encourage same-day decisions, but filler deserves time for assessment and observation. Build in a buffer for swelling or bruising and avoid placing the appointment immediately before a flight, wedding, photography session or other fixed event.
Bring the dates and product names of prior injections. Ask for a written record of the product, lot, amount, areas, clinician and aftercare, plus a contact route that works after you leave Korea. If you have upcoming dental treatment, illness or another procedure, share that timing before injection.
Le Moir's philosophy of individualized treatment fits the current preference for restraint: the goal is not to use a full syringe because it appears on a menu, but to decide whether a specific product and amount support the face without making the treatment the first thing people notice.
PRICE CONTEXT · AUGUST 2026
What a fair comparison includes
All three references use one published Belotero syringe or 1 cc/1 mL, but they do not confirm the same Belotero variant or treatment area. They are market context—not a like-for-like savings calculation.
| Market | Price | Comparison basis |
|---|---|---|
| United States | $475 | Belotero Balance · one syringe · area and consultation vary |
| Europe | €220(≈ $254) | Belotero · 1 mL · multiple facial-area examples · exact variant not named |
| Le Moir · Seoul | ₩300K(≈ $211) | Belotero · 1 cc · full-face menu reference · before VAT · exact variant not named |
Approximate USD conversions use ECB reference rates published 6 August 2026: €1 = $1.1542 and ₩1,424 ≈ $1. Amounts are rounded; card and bank rates vary ECB reference rates.
Le Moir's published figure is numerically below the cited US and European references after conversion. No verified savings percentage is claimed because the exact Belotero variant, treatment area, injector and inclusions do not fully match. Request a written quote naming the sealed product, 1 cc amount, area, clinician and VAT before travel.
COMMON QUESTIONS
Before you book
Does Belotero always create a natural-looking result?
No filler can guarantee that. Product choice, facial anatomy, area, tissue plane, amount, previous filler and injector technique all affect the result. A subtle plan may use less, stage treatment or recommend no filler.
Are Belotero Balance, Volume and Intense the same product?
No. They belong to the same product family but have different characteristics and approvals. Ask to see the exact sealed syringe and confirm its locally authorized use for the planned area.
Is 1 cc a small amount of facial filler?
It is a package volume, not a universal measure of a subtle result. Its visible effect depends on the product, area, tissue characteristics and distribution. The doctor should recommend an amount only after examining the face.
Can hyaluronic-acid filler always be dissolved safely?
Hyaluronidase may reduce some hyaluronic-acid filler in appropriate circumstances, but removal can be incomplete and carries risks. It is not a reason to treat filler as easily reversible or free of serious complications.
What symptoms after filler need urgent attention?
Unusual or severe pain, vision changes, white, gray or blue skin near the injection site, sudden weakness, facial drooping, speech difficulty, severe headache, dizziness or confusion require immediate medical assessment.
SOURCES & FURTHER READING
Check the original information
- AAFPRS — 2026 release on the shift toward subtle, natural-looking results
- US FDA — Belotero Balance (+) approval and 1 mL presentation
- US FDA — Belotero Volume (+) Lidocaine approval P250020
- US FDA — Belotero Intense (+) Lidocaine approval P250016
- Belotero — official US consumer safety information
- US FDA — dermal filler benefits, approved uses and risks
- Le Moir Clinic — current treatment price guide
- Le Moir Clinic — Prestige Contouring program and imported filler availability
- NCEENT — public US Belotero Balance per-syringe price
- Faceland Belgium — public Belotero 1 mL treatment prices
- European Central Bank — euro reference exchange rates
Published August 7, 2026 · Last reviewed for factual accuracy August 7, 2026. Product availability, regulation and clinic pricing can change.



